Anaesth Crit Care Pain Med. 2026 Nov 14:101992. doi: 10.1016/j.accpm.2026.101992. Online ahead of print.
ABSTRACT
BACKGROUND: Microaxial flow pumps (mAFP) improve hemodynamics and outcomes in myocardial infarction-related cardiogenic shock (CS) but are associated with an increased risk of acute kidney injury (AKI) requiring renal replacement therapy (RRT). We aimed to determine the incidence and factors associated with RRT and evaluate its association with mortality in a real-world cohort of miscellaneous CS patients supported with mAFP.
METHODS: We conducted a retrospective multicentre registry including CS patients supported with mAFP across 11 European centres. The association between RRT and the primary outcome of 180-day all-cause mortality (with survival censored at heart transplantation or durable left ventricular assist device implantation) was assessed using a 1:1 propensity score-matched cohort. Factors associated with RRT were identified using multivariable logistic regression.
RESULTS: Among 1043 patients, 972 were included, of whom 340 (35.0%) required RRT. RRT was associated with higher 180-day all-cause mortality both before (Kaplan-Meier estimates, 59.7% vs. 35.2%; HR 2.04, 95% CI 1.67-2.49; p < 0.01) and after propensity score matching (59.0% vs. 41.4%; HR 1.48, 95% CI 1.14-1.92; p < 0.01); restricted mean survival difference -25.5 days, 95% CI - 39.9 to -10.2. Factors associated with RRT included BMI ≥ 30 kg/m² (adjusted OR [aOR] 1.69; 95% CI 1.15-2.46), baseline serum creatinine (per 20 µmol/L increase: aOR 1.18; 95% CI 1.12-1.24), norepinephrine use (aOR 1.72; 95% CI 1.19-2.49), and lactate ≥4 mmol/L at implantation (aOR 1.56; 95% CI 1.11-2.20).
CONCLUSIONS: In this large European registry of mAFP-supported CS, RRT was frequent and associated with increased 180-day mortality and greater shock severity.
PMID:43033843 | DOI:10.1016/j.accpm.2026.101992